Paul Cottu

Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

Guy Meyer, Zora Marjanovic, Judith Valcke et al. · Archives of Internal Medicine · 2002 · 802 citations

Medicine, Pharmacology, Pharmacotherapy +17

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response

Bogdan Mateescu, Luciana Batista, Mélissa Cardon et al. · Nature Medicine · 2011 · 500 citations

Medicine, Molecular Biology, Oncology +16

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

David Cameron, Julia Brown, Rebecca Dent et al. · The Lancet Oncology · 2013 · 436 citations

Medicine, Oncology, Pharmacology +7

BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.

Jemmie Hoang, Paul Cottu, B Thuille et al. · PubMed · 1997 · 411 citations

Life Sciences, Genetics, Oncology +17

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

Hervé Bonnefoi, Thomas Grellety, Olivier Trédan et al. · Annals of Oncology · 2016 · 281 citations · Full text

Medicine, Oncology, Pharmacology +17